The Health Guide — clear answers, healthier tomorrows

    Conditions and cover

    NHS and private cancer care: access and payment

    Written by Emma Leadbetter, Editor and Copywriter, PremierPMI
    Reviewed by Parvoz Haydarov, Founder, PremierPMI

    Published 15 September 2026 · Last reviewed 30 October 2026 · Next review 30 April 2027 · 9 min read

    The short answer

    NHS cancer care is free and measured against national waiting standards; private care is paid for by insurance or yourself and depends on the provider’s availability. You can use both. NHS rules say buying private care should not cost you your NHS entitlement, but the two must stay separate. Agree who holds your records at each step.

    PremierPMI is an insurance broker, authorised and regulated by the FCA (FRN 1029667). We may receive commission if you take out a policy. How we are funded.

    In this guide6 sections
    NHS 28-day diagnosis measure, August 2026
    78.6%[3]
    NHS 62-day treatment target
    85%[3]
    Government guidance on mixing NHS and private care
    2009[6]
    Waited over 104 days for NHS treatment, August 2026
    ~1,400[3]

    NHS and private care side by side

    1. The NHS publishes how quickly it diagnoses and treats cancer; private providers set their own availability. Read more
    2. You can mix NHS and private care, but the private part has to be delivered separately. Read more
    3. Moving between routes works best when one team is clearly responsible at each step. Read more
    4. NHS waiting figures describe national performance, not your own wait. Read more
    5. Some costs and support are the same whichever route you use. Read more

    How the two routes differ

    Most cancer care in the UK is delivered by the NHS, free at the point of use. Private cancer care is delivered by private hospitals, or by private units within NHS hospitals, and is paid for by insurance or by you. Cancer Research UK explains that people may go private for all of their care or just part of it, and that the main reasons are often speed and choice [1]. Those are possibilities, not promises: private care still depends on a provider having capacity and, if you are insured, your insurer agreeing to pay.

    NHS and private cancer care compared on the practical points — scroll sideways to see all columns
    PointNHS routePrivate route
    Who paysPublicly fundedInsurer, if eligible, or you
    How you get inGP or other NHS referralUsually a GP or specialist referral, plus insurer approval if claiming
    WaitingMeasured against national standardsDepends on the provider’s availability
    Choice of specialistSome choice, within NHS rulesChoice from the provider or insurer’s list
    MedicinesWhat the NHS funds, including managed accessWhat your policy covers, or what you pay for
    RecordsHeld by your NHS teamHeld by the private provider; shared with consent

    Access to the NHS starts with a referral. The NHS explains you can ask your GP for a specialist referral, but whether you get one depends on what your GP feels is clinically needed [11]. Private specialists also usually expect a referral, and insurers almost always require one before approving a claim.

    The rules for mixing NHS and private care

    Many people use both routes. They might pay for an earlier private consultation and then return to the NHS for treatment, or have NHS treatment and pay privately for a medicine the NHS does not fund for them. Government guidance for the NHS in England sets the principles. Patients who choose to buy additional private care should not lose the NHS care they are entitled to, but the NHS and private parts must be kept clearly separate [6].

    The guidance followed a review of access to medicines by Professor Sir Mike Richards, which is why it matters most for cancer [6]. In practice, separate means separate appointments, separate payment records and clarity about which team is responsible for what. It does not mean you have to choose one route for good.

    Private patients in NHS hospitals

    Some NHS hospitals have private patient units. Being treated there privately is different from being an NHS patient at the same hospital, even if the building and some staff are the same. Ask which status applies to each appointment, and make sure invoices match.

    Using both NHS and private cancer care

    What works well

    • You can buy one specific step without giving up NHS care for the rest [6].
    • A private appointment may come at a different time from an NHS one.
    • You keep access to NHS-funded medicines, including those available through managed access [7].

    What to watch

    • Moving between teams needs careful coordination of records and results.
    • Private costs can grow if one step leads to another.
    • Each route has its own rules on referrals and approvals.

    Moving between routes without gaps

    The biggest practical risk when mixing care is a gap: results that do not reach the right team, a referral that was not made, or confusion about who is following up. A few questions asked early prevent most of these.

    1. Step 1: Tell both teams

      Let your NHS team and private specialist know you are using both routes.

    2. Step 2: Agree who leads

      Ask which team is responsible for your care at each stage, and get it in writing.

    3. Step 3: Ask how results travel

      Confirm how scan results, letters and reports will be shared, and with your consent.

    4. Step 4: Check referrals

      Ask whether moving back to the NHS needs a new referral or a letter from the private specialist.

    5. Step 5: Separate the payments

      Keep private invoices and approvals apart from NHS appointments.

    6. Step 6: Keep your own copies

      Ask for copies of key letters so you can share them if needed.

    If you are insured, the insurer is a third party in this. Ask it before any private step, because moving a consultation privately does not mean later treatment will automatically be covered. Our guide to making a cancer claim covers approvals in detail.

    Reading NHS cancer waiting figures

    NHS England publishes monthly figures against three standards: being told within 28 days whether you have cancer after an urgent referral, starting treatment within 31 days of a decision to treat, and starting first treatment within 62 days of an urgent referral. Cancer Research UK’s analysis of the August 2026 figures reported 78.6% against the 80% target for 28 days and 92.1% against the 96% target for 31 days. For 62 days, it reported 71.9% against an 85% target that has not been met since December 2015, and said around 1,400 people, 8.9%, waited more than 104 days to start treatment [3].

    NHS England cancer standards, August 2026: gap to target in percentage points
    • 28-day diagnosis1.4 pts78.6% vs 80%
    • 31-day treatment3.9 pts92.1% vs 96%
    • 62-day treatment13.1 pts71.9% vs 85%

    Source: Cancer Research UK, 12 October 2026

    Cancer Research UK also notes that, in April to June 2026, people who were diagnosed with cancer were less likely to get an answer within 28 days (54.8%) than people who had cancer ruled out (79.5%) [3]. These figures describe the NHS in England overall. They cannot predict how long any one person will wait, and there is no equivalent national dataset for private cancer care. If timing drives your decision, compare an actual NHS date with an actual private date.

    What stays the same on either route

    Some things do not change with the route. In England, people having treatment for cancer or its effects can apply for a five-year medical exemption certificate for free NHS prescriptions [5]. Cancer is treated as a disability under the Equality Act 2010 from diagnosis [8], which matters for work and services. And the extra costs of living with cancer, such as travel and lost income, affect people on both routes; Macmillan found people with cancer were on average £570 a month worse off [4].

    Macmillan’s support line is open to everyone on 0808 808 00 00, seven days a week [10]. Your NHS team can also point you to local support, whichever route you use for treatment.

    Questions to ask before mixing care

    A short list of questions, asked of both teams before a private step, prevents most problems. Write the answers down and keep them with your other papers.

    Questions to ask your NHS team and private provider before mixing care — scroll sideways to see all columns
    AskQuestion
    NHS teamWhat happens to my NHS appointments while the private step goes ahead?
    NHS teamWill I need a new referral to come back after private care?
    Private providerWill you send letters and results to my NHS team, with my consent?
    Private providerWhat exactly does your price include, and what is billed separately?
    Insurer, if claimingIs this private step approved, and does it affect later stages?

    Answers will differ between hospitals, so ask locally rather than relying on someone else’s experience.

    If you have private insurance, add one more question for the insurer: if I move back to the NHS for part of my care, does that affect what you will pay later? Some people step in and out of private care several times, and each move is easier when the insurer knows in advance. The FCA’s Consumer Duty expects insurers to support customers in understanding their cover [2], so ask for a clear answer and keep it with your papers. A single page summarising which team is responsible for each part of your care, and who pays, is worth its weight in gold during a long treatment.

    Keep that summary with your claim papers, and give a copy to anyone helping you manage appointments.

    Looking at cover with PremierPMI

    PremierPMI is a specialist private medical insurance broker and the publisher of The Health Guide. If you want to talk through what this means for your own cover, you can start there.

    Or, if you would rather start here, send an enquiry and PremierPMI will contact you.

    PremierPMI is an insurance broker, authorised and regulated by the FCA (FRN 1029667). We may receive commission if you take out a policy. How we are funded.

    Common questions

    Can I switch from NHS to private cancer treatment part-way through?
    Yes. You can move to private care at any stage, and you can move back. Department of Health and Social Care guidance says buying additional private care should not cost you your NHS entitlement, provided the private and NHS parts are kept separate [6]. Before moving, tell your NHS team, ask how records and results will be shared, and confirm whether returning later needs a new referral. If you are insured, contact the insurer before booking anything private, because it will need to approve the care. Keep copies of key letters so you can share them with either team.
    Will I lose my place on the NHS list if I go private?
    Using private care for one part of your treatment should not, on its own, remove your entitlement to NHS care, according to government guidance [6]. However, if you have a particular treatment privately, the NHS will not normally provide the same treatment again in parallel. Talk to your NHS team about what happens to any NHS appointments you have booked, and whether you should keep them while the private step goes ahead. Ask for the answer in writing so there is a clear record of what was agreed with each team.
    Can I pay privately for a cancer drug the NHS won’t fund?
    Often you can, and keep your other NHS care. That situation is what the 2009 government guidance was written for, following a review of access to medicines [6]. The private medicine must be given separately from your NHS care, which usually means separate appointments. Ask your NHS team how this would work at your hospital. Before paying, also check whether the medicine is available on the NHS through NICE’s managed access arrangements, which let people receive some promising new medicines while more evidence is collected [7].
    Is private cancer care always faster than the NHS?
    Not always. Cancer Research UK lists speed as one possible reason people choose private care, along with choice [1], but private availability depends on the provider’s capacity and, if you are insured, the insurer’s approval. NHS figures for August 2026 showed 78.6% of people were told within 28 days whether they had cancer [3], which means many people do get quick answers on the NHS. National figures cannot predict your own wait. Compare the date your NHS team can offer with a confirmed date from a named private provider.
    Do I need a GP referral for private cancer care?
    Usually, yes. Most private specialists expect a referral, and insurers almost always require one before approving a claim. The NHS explains you can ask your GP for a referral to a specialist, though whether you get an NHS referral depends on what your GP feels is clinically needed [11]. If you are paying yourself, some private services accept self-referral for certain tests, but a referral helps your GP stay informed and makes moving between NHS and private care easier. Ask the provider what it needs before booking.
    How do my NHS and private doctors share information?
    With your consent, they can write to each other and share results, but it does not always happen automatically. Ask each team how it will share letters and scan results, and confirm who is responsible for your care at each stage. Keep your own copies of important letters, so you can pass them on if something goes missing. If you are insured, the insurer may also ask your doctors for information; the Access to Medical Reports Act gives you rights to see reports written about you by doctors who usually treat you [9].

    Sources and methodology

    1. [1] Cancer Research UK. “Private cancer treatment”. Published Accessed 30 October 2026. View source(opens in a new tab)Primary source
    2. [2] Financial Conduct Authority. “The Consumer Duty”. Published Accessed 30 October 2026. View source(opens in a new tab)Primary source
    3. [3] Cancer Research UK. “Cancer waiting times: latest updates and analysis”. Published 12 October 2026. View source(opens in a new tab)Primary source
    4. [4] Macmillan Cancer Support. “Cancer – a costly diagnosis?”. Published 2019. View source(opens in a new tab)Primary source
    5. [5] NHS Business Services Authority. “Medical exemption certificates”. Published Accessed 30 October 2026. View source(opens in a new tab)Primary source
    6. [6] Department of Health and Social Care. “Guidance on NHS patients who wish to pay for additional private care”. Published 23 March 2009. View source(opens in a new tab)Primary source
    7. [7] National Institute for Health and Care Excellence. “Managed access”. Published Accessed 30 October 2026. View source(opens in a new tab)Primary source
    8. [8] legislation.gov.uk. “Equality Act 2010, Schedule 1, paragraph 6”. Published 1 October 2010. View source(opens in a new tab)Primary source
    9. [9] British Medical Association. “Access to medical reports”. Published September 2024. View source(opens in a new tab)Primary source
    10. [10] Macmillan Cancer Support. “Benefits and financial support”. Published Accessed 30 October 2026. View source(opens in a new tab)Primary source
    11. [11] NHS. “Referrals for specialist care”. Published Accessed 30 October 2026. View source(opens in a new tab)Primary source

    We cite primary sources wherever possible. Read about our sourcing methodology.

    Written by

    Emma Leadbetter

    Editor and Copywriter, PremierPMI

    • 15 years health, finance and consumer journalism
    • PhD candidate, University of Chichester

    Emma has written across health, finance and consumer-affairs journalism for more than 15 years, and has been part of the PremierPMI team since 2022. She is known for making complex topics easy to understand, and fact-checks every guide against current insurer wording before it goes live. She is completing a PhD at the University of Chichester researching how the NHS has changed since COVID-19.

    Read full profile

    Reviewed by

    Parvoz Haydarov

    Founder, PremierPMI

    • Founder of PremierPMI
    • Whole-of-market private medical insurance

    Parvoz founded PremierPMI as a specialist private medical insurance brokerage. He sets the direction of the firm — insurer relationships, service standards, compliance culture and the editorial bar for everything published under the PremierPMI name — and personally reviews the largest corporate and family cases before they go to market.

    Read full profile